HOME >> BIOLOGY >> NEWS
Progenika Biopharma presents a biochip that guarantees safety in blood transfusions

agnosis (for diagnoses, prognoses and the prediction of and response to treatment of human diseases). So, in 2004 Progenika launched the LIPOchip on to the market, for the diagnosis of Family Hypercholesterolemia, the first biochip with the CE label and on sale since 2004. Progenika currently has 3 products that are at a development phase and which will finalise at the end of the year.


'"/>

Contact: Irati Kortabitarte
iratik@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
4-Jul-2007


Page: 1 2

Related biology news :

1. Science survey ranks top Biopharma employers
2. FDA grants Accentia Biopharmaceuticals...
3. Accentia Biopharmaceuticals announces option agreement with Mayo
4. AutovaxID-C introduced by Accentia Biopharmaceuticals
5. Accentia Biopharmaceuticals acquires exclusive license
6. Accentia Biopharmaceuticals, Inc. launches CRSFungal Profile
7. SNM presents awards on Capitol Hill
8. ESA presents the sharpest ever satellite map of Earth
9. New book presents neurobiology from an evolutionary perspective
10. Lighting up life: Cold Spring Harbor Protocols presents tips for creating glowing plants
11. Childrens Hospital and Research Center-Oakland presents a new maternal diet study

Post Your Comments:
(Date:6/8/2015)... SAN DIEGO , June 8, 2015  Trovagene, Inc. ... announced today that clinical data featuring its Precision Cancer Monitoring ... Cancer Markers and Liquid Biopsies conference in San ... the AACR Precision Medicine Series: Integrating Clinical Genomics and ... on June 13-16. "We continue ...
(Date:6/5/2015)... GERMANTOWN, Md. , June 5, 2015  Intrexon ... synthetic biology, today announced that it has determined the ... of all of its 17,830,305 shares of ZIOPHARM Oncology, ... or about June 12, 2015, the distribution date, as ... stock, and on warrants to purchase shares of Intrexon ...
(Date:6/1/2015)... -- According to a new market research ... (Touch-based & Touchless), Application (Consumer Electronics, Automotive, & Others), ... Global Forecast to 2020", published by MarketsandMarkets, the Gesture ... $23.55 Billion by 2020, at a CAGR of 28.23% ... market data T ables and   86   ...
Breaking Biology News(10 mins):Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 2Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 4Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 2Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 3Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 4Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 2Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 3Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 4
(Date:6/26/2015)... MUMBAI, India , June 26, 2015 ... a leading global IT services, consulting and business solutions ... Leader in Worldwide Life Sciences R&D Risk-Based Monitoring by ... MarketScape: Worldwide Life Science R&D Risk-Based Monitoring 2015 Vendor ... The report evaluated eight leading IT services vendors with ...
(Date:6/26/2015)... ... June 26, 2015 , ... ReliantHeart, Inc. , an innovative supplier of ... implant of the HeartAssist5® LVAD (HA5) to the 68th consecutive implant, there has been ... originates in an LVAD is referred to as de novo thrombus. De novo thrombus ...
(Date:6/25/2015)... ... 2015 , ... Students entering the new Hemenway Hall addition ... exclusively using filtered fume hoods that feature Erlab’s GreenFumeHood Filtration Technology . ... needed for their Organic, Inorganic, Analytical, and Physical Chemistry teaching laboratories. Each filtered ...
(Date:6/25/2015)... , June 25, 2015 /PRNewswire/ - Portage Biotech ... , OTC Markets : PTGEF,), is pleased to announce ... US$5,155,080 through issuance of approximately 36.8 million common shares ... two tranches, first tranche closed on June 15, 2015 ... and second and final tranche closed on June 24, ...
Breaking Biology Technology:TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 2TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 3TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 4HeartAssist5® Remote Monitoring has alerted no patterns of de novo thrombus in 68 consecutive implants 2HeartAssist5® Remote Monitoring has alerted no patterns of de novo thrombus in 68 consecutive implants 3This Summer Erlab Completes the Largest Installation of Filtered Fume Hoods in the World 2Portage Completes Non-brokered Private Placement in Two Tranches for a Total Proceeds of US$ 5,155,080 2Portage Completes Non-brokered Private Placement in Two Tranches for a Total Proceeds of US$ 5,155,080 3
Cached News: